The air we breathe contains a great variety of fungi which may have profound effects on the health of, man. Acting as aero-allergens, fungi may cause rhinitis, asthma, bronchitis, bronchiectasis, allergic pneumonia, alveolitis and diffuse pulmonary fibrosis. Alternatively, with a fungus acting as a tissue invader, serious pulmonary infection may occur. On the other hand fungi may be present in the sputum merely as harmless saprophytes. Evaluation of the role of fungi in a patient's illness is an important diagnostic problem for physicians working in the field of respiratory medicine. In order to make a clinical diagnosis, knowledge of the biological properties of the fungus on the one hand and the immunological reaction of the host on the other is necessary.
Clinical reactions to fungal inhalation may be classified as saprophytic, infective disease and allergic disease. The immunological status of the host is critical in determining all three reactions to fungi. The saprophytic role is related to the normality of the host defences and the generally nonpathogenic nature of the organism. The temperature of fungal growth is important. Some fungi, like aspergillus and candida, grow readily at body temperature and are mainly saprophytic but occasionally invasive. Others, such as cladosporium, growing best at 22°C, cannot grow at body temperature and are therefore neither saprophytes nor invaders. However, this group is important as aero-allergens.
Fungal Infection
Infectious disease is mediated by two principal factors: on the one hand high pathogenicity of the fungus and on the other low host defences permitting opportunistic infections by fungi of low pathogenicity. Very pathogenic organisms such as Histoplasma capsulatum, when inhaled, will generally infect normal subjects. Thus, in parts of the USA 90% of the population show skin test evidence of previous infection but only a minority show clinical evidence of disease.
Opportunistic fungal infections in immunologically compromised patients present a problem rapidly increasing in frequency. Immunity is especially jeopardized by malignant disease or by immunosuppressant drugs used in treatment. Meyer and his colleagues (1973) at the Sloan-Kettering Cancer Center, New York, found over a seven-year study period that the incidence of aspergillosis had quadrupled. Of those dying of acute leukemia, 40% had aspergillosis. The disease is predominantly pulmonary. Clinical features are those of bronchopneumonia, pulmonary heemorrhages and a characteristic syndrome mimicking pulmonary embolism with infection. Aspergillosis was the principal cause of death in most cases. The eradication of bacteria by antibacterial agents leaves the way open for drug-resistant fungal infections. Cytotoxic drugs, corticosteroids and the malignant disease itself cause immune deficiency. Impairment of T cell rather than B cell function is conducive to fungus infections, but the known close interrelation between T and B cells suggests that impairment of either may render the patient more susceptible to fungi. Fungal lung infection in immunosuppressed patients is usually due to Aspergillus fumigatus, Candida albicans, Nocardia and Cryptococcus neoformans. The early diagnosis of these infections, though difficult, is essential, since they are all curable if chemotherapy is started early enough. Wet films of sputum are of great value when appropriately stained for organisms. A special problem here is the isolation of candida. Candida occurs in 50 % of sputa from normal patients on antibiotics as a result of its saprophytic growth in the upper respiratory tract. The diagnosis of pulmonary candidiasis must be supported by the proof that candida is growing in the lower respiratory tract, and for this material must be obtained from the lower respiratory tract. Transcricoid bronchial lavage is of great value because it gives clear-cut evidence of fungi growing in the lower respiratory tract. Alternatively fungal mycelium may be seen on bronchoscopy (bronchial thrush). Aspergillus precipitins should always be sought and are positive in about 50%. Pleural aspiration is helpful where fluid is present. Lung biopsy may be the only method of diagnosis and should not be long delayed; early recourse to this is necessary since specific treatment must be started early if life is to be saved.
Local corticosteroids encourage superficial mucosal mycosis. Beclomethasone aerosol 800 ,ug daily given to asthmatics for 28 weeks resulted in oropharyngeal candidiasis in 77 % compared with only 9% of those receiving placebo and oral corticosteroids (Brompton Hospital/Medical Research Council 1974) . Sensitization to candida occurred in the study as shown by the development of candida precipitins in 16% of patients. Clinical candida allergy or candida pneumonia was not observed in these patients. Pepys et al. (1968) found that in patients with precipitins to candida, injections of candida antigens into the skin could produce immediate (Type 1) and late (Type HI) skin reactions and bronchial challenge produced similar immediate and late reactions. Candida precipitins are commonly found in patients with idiopathic pulmonary eosinophilia though a causal relationship has not yet been established. Thus there are a number of potential hazards for allergic patients with candida overgrowth as a result of aerosol corticosteroids therapy, and their importance needs to be assessed by long-term follow up.
Fungal Allergy
Respiratory fungal allergy is usually a disease of atopic individuals resulting in rhinitis and asthma and less frequently a disease of normal non-atopic individuals causing extrinsic allergic alveolitis. The variety of fungal spores in the atmosphere is great. Gregory (1973) illustrates 116 varieties in his book. The concentration of aerospores may be enormous. Thus a person near a threshing machine may inhale a quarter ofa million spores per minute (Lacey & Lacey 1964) . The site of deposition in the respiratory tract depends on the spore size, those of 1-5 ,um diameter being depbsited mainly in alveoli and those of 10-20 ,um in bronchi and trachea.
Clinical Response to Aspergillus
In order to illustrate the wide variety of different responses occurring in man to inhalation of the same fungus I take as my example aspergillus, the spores of which are of 1-2 ,um diameter, a size ideal for inhalation. The human response to aspergillus may be analysed by simple clinical tests comprising skin tests, bronchial tests and tests for serum precipitins (Table 1 ). The use of these tests by the clinician is essential in evaluating the importance of aspergillus in a patient. The prick test elicits an immediate wealing response developing in ten minutes (Type I). The intracutaneous injection of the protein fraction of aspergillus may elicit an immediate reaction and also a late reaction (Type UII). Where both occur, it is known as a dual reaction. This late reaction appears at about six hours, and may increase over the next twenty-four hours. It is diffuse and non-irritant. A late reaction is suppressed by corticosteroids but the immediate reaction is not. In patients with bronchopulmonary aspergillosis, similar reactions can be demonstrated by the bronchial challenge test. There is early airways obstruction developing after about ten minutes; this is transient and easily reversed by isoprenaline. The late reaction occurs after 6-8 hours, is prolonged, more severe, poorly reversed by isoprenaline, and is often associated with fever, leukocytosis and peripheral lung shadows. Corticosteroids, as with the skin reaction, also inhibit late bronchial reactions but not immediate reactions. Chromoglycate inhibits both. There is a close relation between dual skin and dual bronchial reactions, and hence the bronchial challenge test is rarely required in clinical practice (McCarthy & Pepys 1971) .
Patients with aspergillus infections can generally be demonstrated, by simple double diffusion techniques, to have precipitating antibodies to aspergillus. Precipitin arcs are demonstrable, up to 3 in allergic aspergillosis and 3-8 in aspergilloma, the aspergilloma pattern (Longbottom et al. 1964 ). These precipitins are mainly IgG but some are IgM and IgA. The occurrence of dual skin and bronchial reactions in patients with aspergillosis raises two questions.
(1) What are the immunological mediators of the reactions? (2) What is their clinical significance? Immediate skin reactions are usually mediated by IgE long-term antibody which is characteristic of atopic subjects. In addition Type I reactions in non-atopic subjects may be mediated by IgG short-term antibody (Parish 1970) . The properties of IgE long-term antibody and IgG short-term antibody differ in important respects. IgE persists for weeks on mast cells, whereas IgG persists for a short time and in passive transfer experiments challenge must occur within four hours if a reaction is to be elicited. Eosinophilia is absent with IgG reactions but characterizes IgE reactions. Histamine liberation from mast cells following antigen antibody reactions is 500 times less with IgG than with IgE antibody. Because of its weak liberating properties IgG short-term antibody is unlikely to mediate asthma but it may play an important role as an introductory mechanism to Type m reactions occurring in otherwise non-atopic individuals (see below).
Pepys (1973) has produced convincing evidence that late skin reactions are Type m Arthus response mediated by precipitins. Type III reactions are complement-dependent immune complex reactions. They occur in the presence of moderate antigen excess when antigen-antibody immune complexes are formed which are soluble. Complement is activated and neutrophil polymorphs are attracted. Ingestion of immune complexes by polymorphs and their subsequent destruction liberates lysozymes causing local necrotic reactions. Support for Arthus Type m reactions as the cause of late skin reactions lies in the characteristic time sequence, the histological appearance of perivascular cuffing by inflammatory cells and the immunofluorescent evidence of IgG and complement in the lesions. It is clear that the mere presence of precipitins is insufficient to mediate Arthus reactions. In aspergillomas large quantities of precipitins are present but most patients do not have late skin reactions. Pepys (1973) contends that an introductory Type I reaction is essential before precipitating mediated Type HII reactions can occur. Support for the interdependence of reagenic and precipitating antibodies was obtained by Golbert & Patterson (1970) , who infused into a monkey the serum of a patient containing both reagenic and precipitating antibodies to aspergillus. On lung challenge of the monkey, bronchial late reactions and lung shadows similar to those of the human donor occurred. Infusion of serum containing only reagens produced no such reactions. Bronchial challenge tests in some conditions, such as avian lung, may produce a late reaction without any evidence of immediate reaction. However, more sensitive methods of following bronchial reaction by specific airways conduction may show that there is in fact a small immediate reaction too weak to be detected by conventional FEV1 measurements (Chan-Yeung 1973) . This weak reaction might be mediated by IgG short-term antibody reaction which causes little histamine release and hence little asthma. This hypothesis is supported by the detection of IgG short term antibody in patients with avian lung (Pepys & Parrish 1974, personal communication) .
However, not all skin reactions which have the time characteristics oflate reactions are necessarily Type HI. Dolovich et al. (1973) were able to produce dual skin reactions by the intracutaneous injection of antiserum to human IgE. Similar appearances were given by passive transfer and Prausnitz-Kustner tests. Histologically there was perivascular infiltration with eosinophils. Immunofluorescent stains failed to produce evidence of IgG, IgM or IgA, or components of complement compatible with Type III reactions. Table 2 lists the types of lung disease associated with aspergillus and their diagnosis by means of skin, bronchial and serological tests. The isolation of aspergillus from the sputum is an indication for immunological assessment of its significance. Aspergillus may be found in the sputum of 5 % of individuals in whom its role is entirely saprophytic; this is shown by the absence of any skin allergy and the absence of precipitins (Pepys et al. 1959) . Asthma and rhinitis due to inhalation of aspergillus spores occur in patients who have immediate but not late reactions and no precipitins since they are not infected. Symptoms are worse in autumn and winter when aspergillus spores are most plentiful. In allergic bronchopulmonary aspergillosis patients have dual skin reactions and dual bronchial reactions; aspergillus precipi-tins can be demonstrated in almost all cases. In aspergillus mycetoma large amounts of precipitins occur with many linesthe aspergilloma pattern. About a third of the patients have immediate or sometimes dual skin reactions. Invasive aspergillosis may in a proportion of patients have precipitins but no evidence of skin allergy. Extrinsic allergic alveolitis occurs in non-atopic individuals and results from the inhalation of large quantities of Aspergillus clavatus spores in malt workers and Aspergillus flavus spores in farm workers.
In summary, the various diseases due to aspergillus may be distinguished by simple immunological tests.
Allergic Bronchopulmonary Aspergillosis
Study of patients with allergic bronchopulmonary aspergillosis has thrown much light on the immunopathology of lung disease. Patients generally present under the age of 30 years and are highly atopic individuals with a history of preceding atopy, asthma and many positive skin tests. Those presenting later in life have a short preceding history of asthma and are relatively non-atopic with few positive skin tests. Classical symptoms are fever associated with transient lung shadows, eosinophilia, usually wheeze and expectoration of plugs. Lung shadows are of two sorts. Some are nonsegmental shadows that shift rapidly from place to place and from day to day or hour to hour, probably due to an eosinophilic pneumonia. Others are collapse consolidation of segments or lobes and are due to the impaction of mucoid plugs in the bronchus as a result of intrabronchial allergic reactions. The plugs are coughed up and on section show mycelium in the centre of the plug. Aspergillus is rarely found outside the bronchi. However, granulomatous reactions are sometimes found in the lung and occasionally vasculitis. Katz & Kinker (1973) demonstrated in the vascular lesions in allergic aspergillosis, aspergillus antigen, aspergillus antibody and complement strongly supporting the hypothesis that these reactions are Type III in nature. These reactions may result in irreversible bronchopulmonary damage, e.g. bronchiectasis of a characteristic type in which the bronchiectasis is saccular with normal peripheral filling (Scadding 1967) . Extensive lung fibrosis usually in the upper lobes may also occur in the late stage of the disease in which fleeting shadows and asthma are absent and the diagnosis of aspergillosis will be missed unless skin and serological tests for aspergillus are made.
During episodes of pulmonary shadowing very high levels of total serum IgE occur (i.e. 10 000-30 000 units per ml) (Patterson et al. 1973) . It seems likely that much of this IgE represents specific IgE aspergillus antibody, since measurements of total IgE and specific aspergillus IgE by radioallergosorbent tests (RAST) show a parallelism (Turner et al. 1974) . Whether these large increases of serum antibody cause the lung shadows or result from them is undetermined. Cytophilic aspergillus antibodies have been demonstrated by Assem (1974, personal communication) who measured total histamine content of leukocytes and compared it with the proportion released using anti-IgE and by anti-IgG and by various aspergillus antigens. Both IgE and IgG aspergillus cytophilic antibodies occur. The role of these cytophilic antibodies needs further investigation. The T cell is certainly involved in aspergillus allergy. Blast cell transformation to aspergillus antigen has been demonstrated. However, Type IV skin reactions have not been demonstrated and there is no convincing evidence of T cell mediation in aspergillus allergy so far.
Aspergilloma
Pulmonary aspergilloma is characterized radiographically by a rounded shadow with surrounding air halo. The immunological hallmark is the presence of large quantities of aspergillus precipitins in the serum with 3-8 lines evident in doublediffusion testsa pattern which is diagnostic. Aspergillomas usually produce no symptoms, but some cause hmemoptysis which in about 10 % of patients is severe. Occasionally an aspergilloma results in systemic symptoms with fever and weight loss, without asthma or eosinophilia (McCarthy & Pepys 1973) . Corticosteroids suppress symptoms. My preliminary observations suggest that most of these patients have dual skin reactions. On bronchial challenge, however, they have no immediate reaction or asthmatic reaction. However, a late reaction occurs at about six hours after challenge consisting of fever, constitutional upset and leukocytosis. It is possible that this is mediated by precipitins in conjunction with IgG short-term antibody. Levels of serum IgE are within normal limits. Specific RAST aspergillus IgE also appears normal. However, aspergillus precipitins inhibit aspergillus RAST tests; hence RAST tests in the presence of much precipitin must be interpreted with caution. Aspergillus precipitins commonly occur in patients with chronic lung cavities. Thus, among 544 patients with healed tuberculosis where a persistent cavity remained 25% had aspergillus precipitins: 11 % were of the aspergilloma pattern and aspergillomas were present; the remaining 14% had few lines and no evidence of mycetoma.
Four years later all the patients were resurveyed.
Of those initially precipitin positive, a quarter became spontaneously negative. Thus, the presence of precipitins does not necessarily mean that an aspergilloma will develop. However, of those who were initially precipitin negative, 15 % became precipitin positive and about half of these revealed aspergilloma (British Thoracic and Tuberculosis Association 1970) . Observation of the development of precipitins in this type of case may give early evidence of the development of an aspergilloma, and is therefore of practical value.
Extrinsic Allergic Alveolitis due to Aspergillus Extrinsic allergic alveolitis due to hypersensitivity to aspergillus has been observed in malt distillery workers (Channell et al. 1969 ) and in farmers (Patterson et al. 1974) . Extrinsic alveolitis is characterized by the presence of epitheloid granulomas in the lung. Although these reactions appear like Type IV reactions in tuberculosis, there is no evidence that Type IV allergy is implicated here. There is evidence to suggest mediation by a precipitating antibody reaction (Pepys 1973) . If this is so, what is the explanation of the difference between the histology of precipitin-mediated Arthus vasculitis and the granulomas of extrinsic alveolitis ? In immune complex reactions, the presence of moderate antigen excess results in soluble immune complexes which may result in Arthus reactions. On the other hand, the presence of antibody and antigen in equivalence may result in insoluble complexes which result in granulomatous processes (Spector & Heeson 1969) . Hence differences in the concentration of antibody and antigen may explain precipitinmediated granulomas in extrinsic alveolitis.
Scottish malt whisky distillery workers may be exposed to great numbers of Aspergillus clavatus spores arising from germinating malt. An individual exposed to only one session of malt turning will subsequently grow Aspergillus clavatus in his sputum for a month. Channell et al. (1969) surveyed 700 Scottish malt workers and found clinical evidence of extrinsic allergic alveolitis in 5 %. Symptoms consisted of the onset about six hours after exposure of dry cough, dyspnoea, tightness in the chest and fever. Chest X-ray frequently showed generalized pulmonary mottling. The clinical symptoms can be reproduce-d by bronchial challenge with Aspergillus clavatus which in about six hours causes cough, tightness in the chest and fever. There is no airway obstruction and the response is quite different from the asthmatic response occurring in atopic subjects challenged with aspergillus. Skin testing showed that the great majority of the affected subjects are skin-test negative and non-atopic.
Of the 25% of workers who had precipitins to Aspergillus clavatus only about one-third had clinical evidence of alveolitis. It seems likely that all normal non-atopic people heavily exposed to aspergillus spores for prolonged periods will eventually produce precipitins. Sufficiently high exposure may ultimately result in alveolitis. Certainly among Scottish malt workers with precipitins those who had clinical alveolitis were the men with the greatest exposure to aspergillus spores.
Conclusion
It has been my purpose in this Address to illustrate the great variety of respiratory diseases that may be caused by fungi. The same fungus in different individuals causes contrasting clinical pictures. This is the result of differences in the immunological reaction of the host. For the physician, certain simple skin and serological tests have proved practical and essential tools in the diagnosis of fungal infection and allergy.
